Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

5 evidence items · page 1 / 1

61 %The pooled seroprotection rate was 61% in people living with HIV.

Gabonfièvre jaunepublished 2024The Lancet. Global healthPubMeddocument of 5 observations

76 %The pooled seroprotection rate was 76% in an endemic setting.

Gabonfièvre jaunepublished 2024The Lancet. Global healthPubMeddocument of 5 observations

2,895 individualsThe studies comprised 2895 individuals vaccinated 10–60 years ago.

Gabonfièvre jaunepublished 2024The Lancet. Global healthPubMeddocument of 5 observations

47 %The pooled seroprotection rate was 47% in children aged 9–23 months at time of vaccination.

Gabonfièvre jaunepublished 2024The Lancet. Global healthPubMeddocument of 5 observations

94 %The pooled seroprotection rate was 94% among healthy adults in a non-endemic setting.

Gabonfièvre jaunepublished 2024The Lancet. Global healthPubMeddocument of 5 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.